What were Astrazeneca Pharma India Ltd's latest quarterly results?
Astrazeneca Pharma India Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -22.4%
- Revenue Growth YoY: +20.6%
- Operating Margin: 11.0%
Astrazeneca Pharma India Ltd: Stock Analysis & Fundamentals
Updated this weekAstrazeneca Pharma India Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 110.0. ROE: 23.3%. This stock is not currently in the Nifty 500 momentum outperformers list.
Astrazeneca Pharma India Ltd Key Facts
What's Happening
💪Debt reduced 68% YoY — balance sheet strengthening
Key Numbers
Current Price
₹8,442
Dividend Yield
0.38%
Market Cap
21.1K Cr
Valuation
N/AOther Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500
Frequently Asked Questions: Astrazeneca Pharma India Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Astrazeneca Pharma India Ltd's current PE ratio?
Astrazeneca Pharma India Ltd's current PE ratio is 110.0x.
- Current PE: 110.0x
- Market Cap: 21.1K Cr
- Dividend Yield: 0.38%
What is Astrazeneca Pharma India Ltd's price-to-book ratio?
Astrazeneca Pharma India Ltd's price-to-book ratio is 24.2x.
- Price-to-Book (P/B): 24.2x
- Book Value per Share: ₹349
- Current Price: ₹8442
Is Astrazeneca Pharma India Ltd a fundamentally strong company?
Astrazeneca Pharma India Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 29.0%
Is Astrazeneca Pharma India Ltd debt free?
Astrazeneca Pharma India Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹111 Cr
What is Astrazeneca Pharma India Ltd's return on equity (ROE) and ROCE?
Astrazeneca Pharma India Ltd's return ratios over recent years
- FY2024: ROCE 31.0%
- FY2025: ROCE 33.0%
- FY2026: ROCE 29.0%
Is Astrazeneca Pharma India Ltd's cash flow positive?
Astrazeneca Pharma India Ltd's operating cash flow is negative (FY2026).
- Cash from Operations (CFO): ₹-15 Cr
- Free Cash Flow (FCF): ₹4 Cr
- CFO/PAT Ratio: -8% (weak cash conversion)
What is Astrazeneca Pharma India Ltd's dividend yield?
Astrazeneca Pharma India Ltd's current dividend yield is 0.38%.
- Dividend Yield: 0.38%
- Current Price: ₹8442
Who holds Astrazeneca Pharma India Ltd shares — promoters, FII, DII?
Astrazeneca Pharma India Ltd's shareholding pattern (Mar 2026)
- Promoters: 75.0%
- FII (Foreign): 2.8%
- DII (Domestic): 5.8%
- Public: 16.4%
Is promoter holding increasing or decreasing in Astrazeneca Pharma India Ltd?
Astrazeneca Pharma India Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 75.0% (Mar 2026)
- Previous Quarter: 75.0% (Dec 2025)
- Change: 0.00% (stable)
Is Astrazeneca Pharma India Ltd a new momentum entry or an established outperformer?
Astrazeneca Pharma India Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Astrazeneca Pharma India Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Astrazeneca Pharma India Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Astrazeneca Pharma India Ltd?
Astrazeneca Pharma India Ltd investment thesis summary:
What is the future outlook for Astrazeneca Pharma India Ltd?
Astrazeneca Pharma India Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.